title: Health-related quality of life in multiple sclerosis: current evidence, measurement and effects of disease severity and treatment.
abstract: Health-related quality of life (HR-QOL) is an important measure of health in patients with multiple sclerosis (MS), given that MS symptoms affect many aspects of everyday living. Physicians may tend to focus on physical or cognitive changes in patients with MS because these measures involve physician- or psychologist-administered tests rather than patient self-reporting. However, a number of validated instruments are available to evaluate HR-QOL in clinical studies. Several studies have used these instruments to evaluate the effects of traditional disease-modifying therapies (DMTs), i.e. interferon-beta and glatiramer acetate on HR-QOL in patients with MS. The results of many of these studies showed that DMTs improved some aspects of patients' HR-QOL, but study design issues such as small patient numbers or lack of placebo control for comparison have made it difficult to interpret these results. Two large, randomized, placebo-controlled studies of the newest DMT, natalizumab, showed that this therapy resulted in significant improvements in HR-QOL in patients with relapsing MS. Furthermore, the effects of natalizumab on HR-QOL were apparent, regardless of disease characteristics. The natalizumab studies definitively show that HR-QOL measures can be informative in a clinical trial setting and support the position that patient-reported outcomes, including HR-QOL measures, should be included in clinical trials to more fully assess therapeutic efficacy.
authors.affiliation: Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. rudickr@ccf.org
authors.forename: Richard A
authors.initials: RA
authors.lastname: Rudick
authors.forename: Deborah M
authors.initials: DM
authors.lastname: Miller
mesh_terms: D006304:Health Status; D006801:Humans; D009103:Multiple Sclerosis / Q000523:psychology* / Q000628:therapy; D017063:Outcome Assessment, Health Care; D011788:Quality of Life / Q000523:psychology*; D012720:Severity of Illness Index
references.citation: J Neurol Sci. 2003 Dec 15;216(1):113-8
references.pmid: 14607312
references.citation: Neurology. 1996 Jul;47(1):129-39
references.pmid: 8710066
references.citation: Med Care. 1981 Aug;19(8):787-805
references.pmid: 7278416
references.citation: Ann Neurol. 2007 Oct;62(4):335-46
references.pmid: 17696126
references.citation: Am Fam Physician. 2004 Nov 15;70(10):1935-44
references.pmid: 15571060
references.citation: Neurology. 1995 Jul;45(7):1268-76
references.pmid: 7617181
references.citation: Med Care. 1992 Jun;30(6):473-83
references.pmid: 1593914
references.citation: N Engl J Med. 2000 Sep 28;343(13):938-52
references.pmid: 11006371
references.citation: Mult Scler. 2002 Oct;8(5):377-81
references.pmid: 12356203
references.citation: Lancet. 1998 Nov 7;352(9139):1498-504
references.pmid: 9820297
references.citation: BMJ. 1997 May 31;314(7094):1580-3
references.pmid: 9169401
references.citation: Clin Rehabil. 2001 Jun;15(3):247-58
references.pmid: 11386394
references.citation: Mult Scler. 2001 Apr;7(2):137-42
references.pmid: 11424634
references.citation: Can J Neurol Sci. 1999 Nov;26(4):276-82
references.pmid: 10563212
references.citation: Mult Scler. 2006 Apr;12(2):180-6
references.pmid: 16629421
references.citation: Qual Life Res. 1995 Jun;4(3):187-206
references.pmid: 7613530
references.citation: Neurology. 1993 Apr;43(4):655-61
references.pmid: 8469318
references.citation: N Engl J Med. 2006 Mar 2;354(9):911-23
references.pmid: 16510745
references.citation: Arch Phys Med Rehabil. 1996 Apr;77(4):394-8
references.pmid: 8607766
references.citation: Can J Neurol Sci. 1998 Feb;25(1):31-8
references.pmid: 9532278
references.citation: Neurology. 1996 Apr;46(4):907-11
references.pmid: 8780061
references.citation: Lancet. 1994 Jan 29;343(8892):271-5
references.pmid: 7905102
references.citation: Qual Life Res. 1999 Sep;8(6):481-9
references.pmid: 10548863
references.citation: Mult Scler. 2003 Dec;9(6):621-6
references.pmid: 14664477
references.citation: Qual Life Res. 1993 Jun;2(3):169-80
references.pmid: 8401453
references.citation: J Neurol. 1996 Jun;243(6):469-74
references.pmid: 8803821
references.citation: Mult Scler. 1999 Oct;5(5):317-22
references.pmid: 10516774
references.citation: Neurology. 1999 Sep 22;53(5):1098-103
references.pmid: 10496273
references.citation: Brain. 1989 Feb;112 ( Pt 1):133-46
references.pmid: 2917275
references.citation: J Neurol Neurosurg Psychiatry. 2003 Jun;74(6):710-4
references.pmid: 12754336
references.citation: Mult Scler. 2004 Dec;10(6):690-704
references.pmid: 15584496
references.citation: Epilepsy Res. 1996 Oct;25(2):113-8
references.pmid: 8884169
references.citation: N Engl J Med. 2006 Mar 2;354(9):899-910
references.pmid: 16510744
references.citation: Health Qual Life Outcomes. 2006 Dec 12;4:96
references.pmid: 17163989
references.citation: Neurology. 2002 Sep 10;59(5):679-87
references.pmid: 12221157
references.citation: Brain. 2001 May;124(Pt 5):962-73
references.pmid: 11335698
references.citation: Mult Scler. 2001 Apr;7(2):119-30
references.pmid: 11424632
references.citation: Mult Scler. 2000 Oct;6(5):338-42
references.pmid: 11064444
references.citation: Mult Scler. 2006 Dec;12(6):808-13
references.pmid: 17263011
references.citation: Neurology. 2001 Nov 27;57(10):1870-5
references.pmid: 11723278
references.citation: Ann Neurol. 1996 Mar;39(3):285-94
references.pmid: 8602746
references.citation: Int J Qual Health Care. 2000 Dec;12(6):511-7
references.pmid: 11202605
references.citation: Mult Scler. 2008 Mar;14(2):219-30
references.pmid: 17942521
references.citation: Neurology. 2001 Jul 10;57(1):68-74
references.pmid: 11445630
references.citation: Res Nurs Health. 1992 Feb;15(1):29-38
references.pmid: 1579648
references.citation: J Neurol Neurosurg Psychiatry. 2000 Feb;68(2):144-9
references.pmid: 10644777